A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...
Millions with type 2 diabetes face hidden nutrient deficiencies, raising concerns about health risks and the urgent need for dietary intervention.
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
GlobalData on MSN1d
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trialResearchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback